257 related articles for article (PubMed ID: 28704260)
41. Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension.
Wang GK; Li SH; Zhao ZM; Liu SX; Zhang GX; Yang F; Wang Y; Wu F; Zhao XX; Xu ZY
Oncotarget; 2016 Aug; 7(34):54263-54273. PubMed ID: 27472464
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
[TBL] [Abstract][Full Text] [Related]
43. Antitumor efficacy of α-solanine against pancreatic cancer in vitro and in vivo.
Lv C; Kong H; Dong G; Liu L; Tong K; Sun H; Chen B; Zhang C; Zhou M
PLoS One; 2014; 9(2):e87868. PubMed ID: 24505326
[TBL] [Abstract][Full Text] [Related]
44. Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.
Meloche J; Potus F; Vaillancourt M; Bourgeois A; Johnson I; Deschamps L; Chabot S; Ruffenach G; Henry S; Breuils-Bonnet S; Tremblay È; Nadeau V; Lambert C; Paradis R; Provencher S; Bonnet S
Circ Res; 2015 Aug; 117(6):525-35. PubMed ID: 26224795
[TBL] [Abstract][Full Text] [Related]
45. Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Li Q; Wang J; Zhu X; Zeng Z; Wu X; Xu Y; Xie J; Yu J
Biomed Pharmacother; 2017 Dec; 96():825-833. PubMed ID: 29078260
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
Yan D; Li G; Zhang Y; Liu Y
Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
[No Abstract] [Full Text] [Related]
47. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
[TBL] [Abstract][Full Text] [Related]
48. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression.
Xing Y; Zheng X; Li G; Liao L; Cao W; Xing H; Shen T; Sun L; Yang B; Zhu D
Int J Biochem Cell Biol; 2015 Jul; 64():155-66. PubMed ID: 25882492
[TBL] [Abstract][Full Text] [Related]
50. Galectin-3- Mediated Transdifferentiation of Pulmonary Artery Endothelial Cells Contributes to Hypoxic Pulmonary Vascular Remodeling.
Zhang L; Li YM; Zeng XX; Wang XY; Chen SK; Gui LX; Lin MJ
Cell Physiol Biochem; 2018; 51(2):763-777. PubMed ID: 30463073
[TBL] [Abstract][Full Text] [Related]
51. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433
[TBL] [Abstract][Full Text] [Related]
52. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
53. HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.
Nogueira-Ferreira R; Ferreira-Pinto MJ; Silva AF; Vitorino R; Justino J; Costa R; Moreira-Gonçalves D; Quignard JF; Ducret T; Savineau JP; Leite-Moreira AF; Ferreira R; Henriques-Coelho T
J Cell Physiol; 2017 Nov; 232(11):3128-3138. PubMed ID: 28036116
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
[TBL] [Abstract][Full Text] [Related]
55. Lumican deficiency promotes pulmonary arterial remodeling.
Lai YJ; Kao WW; Yeh YH; Chen WJ; Chu PH
Transl Res; 2021 Nov; 237():63-81. PubMed ID: 34091085
[TBL] [Abstract][Full Text] [Related]
56. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
57. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of Klotho potentially inhibits pulmonary vascular remodeling by blocking the activation of the Wnt signaling pathway in rats with PM2.5-induced pulmonary arterial hypertension.
Cong LH; Du SY; Wu YN; Liu Y; Li T; Wang H; Li G; Duan J
J Cell Biochem; 2018 Jul; 119(7):5581-5597. PubMed ID: 29380911
[TBL] [Abstract][Full Text] [Related]
59. Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension.
Chen J; Sysol JR; Singla S; Zhao S; Yamamura A; Valdez-Jasso D; Abbasi T; Shioura KM; Sahni S; Reddy V; Sridhar A; Gao H; Torres J; Camp SM; Tang H; Ye SQ; Comhair S; Dweik R; Hassoun P; Yuan JX; Garcia JGN; Machado RF
Circulation; 2017 Apr; 135(16):1532-1546. PubMed ID: 28202489
[TBL] [Abstract][Full Text] [Related]
60. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
